Affiliation:
1. Faculty of Medicine , Ovidius University of Constanta , Romania
2. Carol Davila University of Medicine and Pharmacy , Bucharest , Romania
Abstract
Abstract
People living with HIV live longer now due to highly active antiretroviral therapy. Due to their increased life expectancy, they have an increased cardiovascular risk cause by the traditional risk factors (smoking, use of ilicit drugs, obesity/lipodystrophy, dyslipidemia, diabetes, hypertension) and particular risk factors (endothelial dysfunction, inflammation, coagulation abnormalities, viral coinfections and antiretroviral therapy. The pathophysiology of accelerated atherosclerosis is complex. Coronary artery disease become an important cause of mortality in these patients. The incidence of coronary artery disease and especially of acute myocardial infarction is generally low among HIV patients, but it may by twice as high as in patients with the similar characteristics. Medical treatment for coronary disease in these patients has no special particularities comparing to general population, but possible drug interactions must be considered. Indication for coronary revascularization, either angioplasty, or aorto-coronary by-pass follows general indications for general population.
Reference19 articles.
1. 1. Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, van Sighem A V., et al. Future challenges for clinical care of an ageing population infected with HIV: A modelling study. Lancet Infect Dis. 2015;10.1016/S1473-3099(15)00056-0
2. 2. Freiberg MS, Chang CCH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;10.1001/jamainternmed.2013.3728476679823459863
3. 3. May M, Gill J, Lewden C, Saag M, Mugavero M, Reiss P, et al. Causes of death in HIV-1-Infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;
4. 4. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the Highly Active Antiretroviral Therapy Era. JAIDS J Acquir Immune Defic Syndr. 2006;10.1097/01.qai.0000233310.90484.1616878047
5. 5. Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, et al. Hiv infection and long-term residual cardiovascular risk after acute coronary syndrome. J Am Heart Assoc. 2020;